Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$12.94 - $19.2 $647 - $960
50 New
50 $6,000
Q2 2022

Aug 05, 2022

SELL
$83.14 - $145.99 $4,157 - $7,299
-50 Closed
0 $0
Q3 2021

Oct 05, 2021

BUY
$98.85 - $138.91 $4,942 - $6,945
50 New
50 $7,000
Q3 2019

Oct 31, 2019

SELL
$37.38 - $49.47 $1,794 - $2,374
-48 Closed
0 $0
Q2 2019

Jul 19, 2019

BUY
$39.79 - $67.01 $1,909 - $3,216
48 New
48 $2,000
Q1 2019

May 08, 2019

SELL
$34.52 - $53.29 $1,415 - $2,184
-41 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$32.79 - $43.0 $1,344 - $1,763
41 New
41 $2,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.56B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Hanseatic Management Services Inc Portfolio

Follow Hanseatic Management Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hanseatic Management Services Inc with notifications on news.